학술논문

A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS
Document Type
Article
Source
In: Annals of Clinical and Translational Neurology. (Annals of Clinical and Translational Neurology, January 2022, 9(1):50-66)
Subject
Language
English
ISSN
23289503